Deep Tech Startups

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms. It focuses on antibody and antibody-drug conjugate modalities to treat oncology patients.

8 investors

Ignota Labs uses SAFEPATH, a proprietary AI platform combining machine learning with bioinformatics and cheminformatics data, to identify and resolve drug safety and toxicity problems. It focuses on drugs that failed in preclinical, Phase 1, or Phase 2 clinical trials due to safety issues, aiming to turn them around and bring them to patients faster.

8 investors

Impossible Metals builds underwater robotic vehicles to collect critical metals from the seabed for clean energy applications, with a focus on sustainable and environmentally responsible extraction practices.

8 investors

Ineffable is an AI research lab focused on building superintelligence through the reinforcement learning paradigm, emphasizing learning from experience in the environment rather than from human data. It aims to advance fundamental AI research toward beneficial superintelligence applicable to any digital or physical machine.

8 investors

Interlune is a space resources company developing technology to harvest natural resources from the Moon and deliver them to customers on Earth and in space. It serves industries including quantum computing, national security, fusion power, and medical imaging.

8 investors

DreamFold builds a protein therapeutics platform that uses AI-driven protein design, generative modelling, and high-throughput screening to develop new classes of protein drugs for diseases lacking effective treatments. It operates in the biotech and AI drug discovery space.

8 investors

KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply. The pre-clinical stage biotech company is supported by federal grants and investor funding.

8 investors

Ligo develops computational tools for enzyme design by combining large language models with specialized neural networks to enable scientists and AI agents to discover new enzymes and biological functions.

8 investors

Liminal Insights uses ultrasound-based technology to provide quality control and inspection for battery cell R&D and manufacturing, targeting battery cell manufacturers and automotive OEMs. Its systems aim to improve battery performance, safety, and cost to help scale production for electric vehicles and grid storage.

8 investors

Magic Leap develops augmented reality hardware and technologies, including AR glasses and waveguide components. The company partners with technology leaders to help them develop and commercialize AR products.

8 investors

Manna operates an air delivery service using drone technology to deliver medical equipment, food, and other goods, with plans to reduce traffic and improve air quality in urban areas.

8 investors

Matterworks builds foundation models (its Large Spectral Model, delivered via the cloud-based Pyxis platform) that analyze biochemical omics and mass spectrometry data to make predictions for life science R&D. It serves discovery, toxicology, clinical development, and biomanufacturing teams with applications such as target discovery, toxicity prediction, and bioprocess optimization.

8 investors

Michroma uses industrial biotechnology and fermentation to produce natural food colorants, offering an alternative to petrochemical-derived synthesis, plant extraction, and animal-based ingredients. It serves food and consumer product companies seeking healthier and more sustainable ingredients.

8 investors

Mission Bio develops single-cell biology tools and platforms for researchers and clinicians to enable precision medicine discovery and cancer treatment. The company serves the biomedical research and clinical diagnostics market.

8 investors

Modern Intelligence builds artificial intelligence software for defense applications, providing target analysis and decision-making from small data samples. Its hardware- and software-agnostic AI integrates across platforms and is aimed at commercial industry and defense customers.

8 investors

Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets. The company operates in drug discovery and pharmaceutical development.

8 investors

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression. The company builds implantable neurotechnology for patients with mental illness and is based in Houston, Texas.

8 investors

Multifactor provides zero-trust authentication, authorization, and auditing services. The company serves developers and end users requiring secure identity verification and access control solutions.

8 investors

Multiply Labs develops cloud-controlled modular robotic systems that manufacture individualized drugs and deploys them in pharmaceutical customers' facilities, selling robotic production capacity as a service. It serves the pharma manufacturing industry producing individualized and next-generation therapies.

8 investors

Nabla is a drug development company that applies design discipline and scientific rigor to the development of new medicines. The company focuses on making drug development more systematic and iterative, serving the pharmaceutical and biotech industry.

8 investors

Noon Energy develops ultra-long-duration battery storage using a reversible solid oxide fuel cell and carbon-based storage media to deliver 100+ hours of clean, firm power. Its systems target commercial and industrial operations, microgrids and islands, and data centers and grid-scale energy applications.

8 investors

nTop provides a software platform for engineering design that uses implicit modeling and physics-based simulation to accelerate product development. The platform enables engineering teams to rapidly iterate on complex designs, reducing development cycles and improving success rates for aerospace, defense, and manufacturing applications.

8 investors

NVision develops quantum computing and quantum-enhanced sensing platforms based on quantum spin control in organic molecules, with focus on healthcare applications including drug development and disease treatment.

8 investors

Orbion Space Technology builds Hall-effect electric propulsion systems for small-satellite constellations, providing integrated thrusters, power processing units, and propellant management for in-space maneuvers. Its AS9100D-certified hardware supports functions like collision avoidance, drag compensation, and orbit transfer for satellite operators.

8 investors